首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1485794

质粒 DNA 製造市场，按等级、按应用、按开发阶段、按疾病、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Plasmid DNA Manufacturing Market, By Grade, By Application, By Development Phase, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年04月13日 | 出版商:

AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2023 年，质粒 DNA 製造市场规模为 17.8898 亿美元，2024 年至 2032 年复合年增长率为 21.5%。

质粒DNA製造市场-市场动态

研发活动的增加以及遗传性疾病和传染病患者的增加推动了市场需求

推动质粒 DNA 製造市场发展的原因有很多，包括研发力度的增加、生物製药投资的增加以及遗传异常和传染病发生频率的增加。此外，精准医学的发展和新免疫疗法的开发正在推动对基于质粒 DNA 的药物的需求。监管进步和审批程序缩短促进了市场扩张，使研究发现更快转化为临床应用。

质粒 DNA 製造市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 21.5% 左右的复合年增长率成长

根据牌号细分，预计研发牌号码将在 2023 年显示最大的市场份额

从应用细分来看，DNA疫苗是2023年的主导类型

根据开发阶段细分，临床前治疗是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

质粒 DNA 製造市场 - 細項分析：

全球质粒 DNA 製造市场根据等级、应用、开发阶段、疾病和地区进行细分。

市场依等级分为三类：研发级、GMP级。研发级产业主导市场。研发级质粒 DNA 广泛用于早期研究和开发，使科学家能够探索新的治疗概念并验证临床前疗效。

根据应用，市场分为两类：DNA 疫苗、细胞和基因治疗、免疫治疗和其他。 DNA 疫苗领域在市场上占据主导地位，并可能在预测期内保持其主导地位。 DNA 疫苗利用免疫系统识别和对抗病原体的能力，为预防传染病和应对新出现的健康威胁提供了一种有前途的方法。

质粒 DNA 製造市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

质粒DNA製造市场-竞争格局：

质粒 DNA 製造市场竞争激烈，知名竞争对手透过新颖的製造工艺和可扩展的生产能力争夺霸主地位。公司利用策略联盟、收购和研发支出来加强其市场地位并扩大其产品范围。领先公司优先考虑品质保证、合规性和经济高效的解决方案，以满足各种应用（包括基因治疗、疫苗研究和生物製药製造）对质粒 DNA 不断增长的需求。为了保持竞争优势，企业必须不断适应不断变化的市场趋势和客户需求。

市场片段
- 按等级分類的质粒 DNA 製造市场片段
- 按开发阶段分類的质粒 DNA 製造市场片段
- 按应用分類的质粒 DNA 製造市场片段
- 按疾病分類的质粒 DNA 製造市场片段
- 按国家/地区分類的质粒 DNA 製造市场片段
- 按地区分類的质粒 DNA 製造市场片段
竞争洞察

第 3 章：质粒 DNA 製造主要市场趋势

质粒 DNA 製造市场驱动因素
- 市场驱动因素的影响分析
质粒 DNA 製造市场限制
- 市场限制影响分析
质粒 DNA 製造市场机会
质粒DNA製造市场未来趋势

第 4 章：质粒 DNA 製造业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：质粒 DNA 製造市场：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：质粒 DNA 製造市场格局

2023 年质粒 DNA 製造市占分析
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：质粒 DNA 製造市场 - 依等级

概述
- 按等级分類的细分市场占有率分析
- 研发级
- GMP级

第 8 章：质粒 DNA 製造市场 - 按开发阶段

概述
- 按开发阶段分類的细分市场占有率分析
- 临床前治疗
- 临床治疗
- 上市治疗药物

第 9 章：质粒 DNA 製造市场 - 按应用

概述
- 按应用分類的细分市场占有率分析
- DNA疫苗
- 细胞与基因治疗
- 免疫疗法
- 其他的

第 10 章：质粒 DNA 製造市场 - 依疾病分类

概述
- 按开发阶段分類的细分市场占有率分析
- 传染病
- 癌症
- 遗传性疾病
- 其他的

第 11 章：质粒 DNA 製造市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美质粒 DNA 製造主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按等级）
- 北美市场规模和预测（按开发阶段）
- 北美市场规模和预测（按应用）
- 北美市场规模与预测（按疾病）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲质粒 DNA 製造主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按等级）
- 欧洲市场规模和预测（按发展阶段）
- 欧洲市场规模和预测（按应用）
- 欧洲市场规模与预测（按疾病）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区质粒 DNA 製造主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（依等级）
- 按发展阶段分類的亚太市场规模和预测
- 亚太地区市场规模与预测（按应用）
- 亚太地区市场规模与预测（按疾病）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲质粒 DNA 製造主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按等级）
- 拉丁美洲市场规模与预测（按发展阶段）
- 拉丁美洲市场规模与预测（按应用）
- 拉丁美洲市场规模与预测（按疾病）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲质粒 DNA 製造主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按等级）
- 中东及非洲市场规模及预测（依发展阶段）
- 中东和非洲市场规模及预测（按应用）
- 中东和非洲市场规模及预测（按疾病）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 12 章：主要供应商分析 - 质粒 DNA 製造业

竞争仪表板
公司简介
- Nature Technology
- Cell and Gene Therapy Catapult
- Danaher (Aldevron)
- Kaneka Corp.
- Eurofins Genomics
- Lonza
- Charles River Laboratories
- VGXI, Inc.
- Luminous BioSciences, LLC
- Akron Biotech
- Others

第 13 章：360 度分析师视角

第 14 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV2696

REPORT HIGHLIGHT

Plasmid DNA Manufacturing Market size was valued at USD 1,788.98 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Global Plasmid DNA Manufacturing Market is seeing substantial expansion and transition, owing to advances in biopharmaceutical study and development. Plasmid DNA, a flexible molecular tool, serves as the basis for a wide range of therapeutic applications, including DNA vaccinations, cell and gene therapy. As the need for personalised medicine and targeted therapies continues to develop, the market for plasmid DNA synthesis is positioned to significantly expand.

Plasmid DNA Manufacturing Market- Market Dynamics

Increasing research and development activities and the rising prevalence of genetic disorders and infectious diseases propel market demand

A variety of reasons are driving the Plasmid DNA Manufacturing marketplace, including increased R&D efforts, increased biopharmaceutical investments, and the rising frequency of genetic abnormalities and infectious illnesses. Furthermore, the move towards precision medicine and the development of new immunotherapies are driving up demand for plasmid DNA-based medicines. Regulatory advances and shortened approval procedures boost market expansion, allowing speedier translation of research discoveries into clinical applications.

Plasmid DNA Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Grade segmentation, R&D Grade was predicted to show maximum market share in the year 2023

Based on application segmentation, DNA Vaccines was the leading type in 2023

Based on Development Phase segmentation, Pre-Clinical Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Manufacturing Market is segmented based on Grade, Application, Development Phase, Disease, and Region.

The market is divided into three categories based on Grade: R&D Grade, GMP Grade. The R&D Grade sector dominates the market. Widely used in early-stage research and development, R&D Grade plasmid DNA enables scientists to explore novel therapeutic concepts and validate preclinical efficacy.

The market is divided into two categories based on application: DNA Vaccines, Cell & Gene Therapy, Immunotherapy, and Others. The DNA vaccine segment dominates the market and is likely to maintain its dominance during the forecast period. Leveraging the immune system's ability to recognize and combat pathogens, DNA vaccines offer a promising approach to preventing infectious diseases and addressing emerging health threats.

Plasmid DNA Manufacturing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Plasmid DNA Manufacturing Market- Competitive Landscape:

The Plasmid DNA Manufacturing Market is competitive, with prominent competitors vying for supremacy via novel manufacturing processes and scalable production capacity. Companies use strategic alliances, acquisitions, and R&D expenditures to strengthen their market position and broaden their product offerings. Leading companies prioritise quality assurance, regulatory compliance, and cost-effective solutions to fulfil the expanding demand for plasmid DNA in a variety of applications, including gene therapy, vaccine research, and biopharmaceutical manufacturing. To sustain their competitive advantage, businesses must constantly adapt to changing market trends and client demands.

Recent Developments:

In February 2023, PackGene Biotech expanded its services with the opening of an innovative GMP biomanufacturing and processing plant in Houston, Texas. This comprises gene therapy programmes that produce cost-effective, dependable, and scalable AAV products. With this development, the business hopes to become a one-stop solution supplier for gene therapy developers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Nature Technology

Cell and Gene Therapy Catapult

Danaher (Aldevron)

Kaneka Corp.

Eurofins Genomics

Lonza

Charles River Laboratories

VGXI, Inc.

Luminous BioSciences, LLC

Akron Biotech

Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2019 - 2032

R&D Grade
GMP Grade

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2019 - 2032

Pre-Clinical Therapeutics
Clinical Therapeutics
Marketed Therapeutics

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

Infectious Disease
Cancer
Genetic Disorder
Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Plasmid DNA Manufacturing Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Plasmid DNA Manufacturing Market Snippet by Grade
- 2.1.2.Plasmid DNA Manufacturing Market Snippet by Development Phase
- 2.1.3.Plasmid DNA Manufacturing Market Snippet by Application
- 2.1.4.Plasmid DNA Manufacturing Market Snippet by Disease
- 2.1.5.Plasmid DNA Manufacturing Market Snippet by Country
- 2.1.6.Plasmid DNA Manufacturing Market Snippet by Region
2.2.Competitive Insights

3.Plasmid DNA Manufacturing Key Market Trends

3.1.Plasmid DNA Manufacturing Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Plasmid DNA Manufacturing Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Plasmid DNA Manufacturing Market Opportunities
3.4.Plasmid DNA Manufacturing Market Future Trends

4.Plasmid DNA Manufacturing Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Plasmid DNA Manufacturing Market Landscape

6.1.Plasmid DNA Manufacturing Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Manufacturing Market - By Grade

7.1.Overview
- 7.1.1.Segment Share Analysis, By Grade, 2023 & 2032 (%)
- 7.1.2.R&D Grade
- 7.1.3.GMP Grade

8.Plasmid DNA Manufacturing Market - By Development Phase

8.1.Overview
- 8.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 8.1.2.Pre-Clinical Therapeutics
- 8.1.3.Clinical Therapeutics
- 8.1.4.Marketed Therapeutics

9.Plasmid DNA Manufacturing Market - By Application

9.1.Overview
- 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2.DNA Vaccines
- 9.1.3.Cell & Gene Therapy
- 9.1.4.Immunotherapy
- 9.1.5.Others

10.Plasmid DNA Manufacturing Market - By Disease

10.1.Overview
- 10.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
- 10.1.2.Infectious Disease
- 10.1.3.Cancer
- 10.1.4.Genetic Disorder
- 10.1.5.Others

11.Plasmid DNA Manufacturing Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Plasmid DNA Manufacturing Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Plasmid DNA Manufacturing Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Plasmid DNA Manufacturing Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Manufacturing Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Nature Technology
- 12.2.2.Cell and Gene Therapy Catapult
- 12.2.3.Danaher (Aldevron)
- 12.2.4.Kaneka Corp.
- 12.2.5.Eurofins Genomics
- 12.2.6.Lonza
- 12.2.7.Charles River Laboratories
- 12.2.8.VGXI, Inc.
- 12.2.9.Luminous BioSciences, LLC
- 12.2.10.Akron Biotech
- 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Plasmid DNA Manufacturing Market: Grade Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Grade
TABLE Global Plasmid DNA Manufacturing Market, by Grade 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Development Phase Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Development Phase
TABLE Global Plasmid DNA Manufacturing Market, by Development Phase 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Plasmid DNA Manufacturing Market, by Application 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Disease Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Disease
TABLE Global Plasmid DNA Manufacturing Market, by Disease 2019-2032 (USD Million)
TABLE Plasmid DNA Manufacturing Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Plasmid DNA Manufacturing Market, by Region 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE North America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Europe Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)

02-2729-4219

+886-2-2729-4219

License/价格

质粒 DNA 製造市场，按等级、按应用、按开发阶段、按疾病、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Plasmid DNA Manufacturing Market, By Grade, By Application, By Development Phase, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

报告要点

质粒 DNA 製造市场 - 細項分析：

质粒DNA製造市场-竞争格局：

最近的发展：

目录

第 1 章：质粒 DNA 製造市场概述

第 2 章：执行摘要

第 3 章：质粒 DNA 製造主要市场趋势

第 4 章：质粒 DNA 製造业研究

第 5 章：质粒 DNA 製造市场：COVID-19 影响分析

第 6 章：质粒 DNA 製造市场格局

第 7 章：质粒 DNA 製造市场 - 依等级

第 8 章：质粒 DNA 製造市场 - 按开发阶段

第 9 章：质粒 DNA 製造市场 - 按应用

第 10 章：质粒 DNA 製造市场 - 依疾病分类

第 11 章：质粒 DNA 製造市场 - 按地理位置

第 12 章：主要供应商分析 - 质粒 DNA 製造业

第 13 章：360 度分析师视角

第 14 章：附录

REPORT HIGHLIGHT

Plasmid DNA Manufacturing Market- Segmentation Analysis:

Plasmid DNA Manufacturing Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.Plasmid DNA Manufacturing Market Overview

2.Executive Summary

3.Plasmid DNA Manufacturing Key Market Trends

4.Plasmid DNA Manufacturing Industry Study

5.Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

6.Plasmid DNA Manufacturing Market Landscape

7.Plasmid DNA Manufacturing Market - By Grade

8.Plasmid DNA Manufacturing Market - By Development Phase

9.Plasmid DNA Manufacturing Market - By Application

10.Plasmid DNA Manufacturing Market - By Disease

11.Plasmid DNA Manufacturing Market- By Geography

12.Key Vendor Analysis- Plasmid DNA Manufacturing Industry

13.360 Degree Analyst View

14.Appendix

List of Tables